FSDDF - FSD Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
72.26M
Enterprise Value 3
44.1M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
245.71
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-81.15%
S&P500 52-Week Change 325.98%
52 Week High 356.88
52 Week Low 33.93
50-Day Moving Average 35.60
200-Day Moving Average 313.23

Share Statistics

Avg Vol (3 month) 37.37k
Avg Vol (10 day) 310.04k
Shares Outstanding 57.82M
Float 6.89M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:201
Last Split Date 3Oct 15, 2019

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.53%
Return on Equity (ttm)-84.71%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-7.40%
Gross Profit (ttm)-313.13k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)3.52
Current Ratio (mrq)1.81
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A